Paxobrook Tablet (Nirmatrelvir + Ritonavir) | Used to Treat Mild COVID-19 in High Risk Patients
Paxobrook Tablet (Nirmatrelvir + Ritonavir) is a combination antiviral medication used primarily for the treatment of COVID-19 in adults and children who are at high risk of developing severe illness. It contains two active ingredients: Nirmatrelvir and Ritonavir.
Product Overview
Paxobrook Tablet is an advanced, dual-action oral antiviral medication meticulously developed to inhibit the replication of viral pathogens within the human host. Containing a co-packaged combination of Nirmatrelvir 150 mg and Ritonavir 100 mg, this therapy acts as a highly targeted viral protease inhibitor regimen. It is primarily utilized for the clinical management and treatment of mild-to-moderate viral infections in adult and pediatric patients who are at high risk for progression to severe disease or hospitalization. By systematically blocking the essential molecular machinery required for viral multiplication, this treatment rapidly lowers viral load, accelerates symptom resolution, and helps protect vital respiratory and systemic functions.
Product Composition
- Nirmatrelvir Tablets: Each pink, film-coated tablet contains 150 mg of Nirmatrelvir, which acts as the primary peptidomimetic inhibitor of the viral 3C-like protease (3CLpro) enzyme.
- Ritonavir Tablets: Each white, film-coated tablet contains 100 mg of Ritonavir, functioning strictly as a pharmacokinetic boosting agent to prevent the premature breakdown of the primary antiviral compound.
- Therapeutic Class: Systemic Antiviral / Protease Inhibitor Combination.
- Key Excipients: Formulated with microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, and colloidal silicon dioxide to ensure optimized tablet stability, rapid breakdown, and consistent ingredient absorption.
Product Specification
| Parameter | Specification Detail |
| Formulation Type | Co-packaged solid oral film-coated tablets |
| Dosing Component Ratio | 2 tablets of Nirmatrelvir (150 mg each) + 1 tablet of Ritonavir (100 mg) per dose |
| Primary Indication | Treatment of mild-to-moderate viral infection in patients at high risk of severe progression |
| Standard Dosing Window | Initiated within 5 days of symptom onset; administered twice daily for 5 consecutive days |
| Metabolic Enhancer | Ritonavir component safely slows hepatic CYP3A metabolism to keep active antiviral levels high |
Mechanism of Action
- Inhibition of Viral 3CL Protease: The Nirmatrelvir component binds directly to the viral 3C-like protease enzyme, a critical protein that the virus absolute requires to slice up long polyprotein chains into functional pieces.
- Halting Viral Replication: By blocking this specific enzyme cleavage, the medication renders the virus completely unable to assemble its structural components, effectively halting viral replication inside the host cells.
- Pharmacokinetic Boosting: The Ritonavir component functions as a potent inhibitor of the host's hepatic CYP3A4 enzyme pathways, slowing down the natural liver breakdown of Nirmatrelvir to maintain highly effective antiviral concentrations in the bloodstream over the dosing cycle.
Key Benefits
- Prevents Disease Progression: Significantly reduces the risk of mild infections turning into severe respiratory complications, helping high-risk individuals avoid emergency hospitalization.
- Convenient At-Home Treatment: Offers a highly effective oral tablet course that can be fully managed at home, eliminating the need for complex intravenous infusions in a clinic.
- Rapid Clearance of Viral Load: Fast-acting dual mechanism works quickly to suppress viral replication, shortening the duration of debilitating symptoms like exhaustion, fever, and coughing.
- Targeted Protease Mechanism: Focuses specifically on viral replication enzymes rather than host cellular mechanisms, maximizing antiviral impact while protecting healthy human cells.
Precautions
| General Precaution | Details |
|---|---|
| Start Early Use | Most effective when started early after infection onset. |
| Complete Full Course | Do not stop treatment midway. |
| Drug Interaction Check | Many medicines may interact with this combination. |
| Liver Monitoring | Use caution in liver disease conditions. |
| Kidney Function | Dose adjustment may be needed in kidney issues. |
| Avoid Self Medication | Do not combine with other antivirals without guidance. |
| Regular Monitoring | Watch for worsening symptoms during treatment. |
Important Usage Precautions
- Use Paxobrook Tablet (Nirmatrelvir + Ritonavir) exactly as directed and complete the full course.
- Inform about all ongoing medicines to avoid harmful interactions.
- Do not skip doses, as it may reduce antiviral effectiveness.
- Monitor for symptoms like breathing difficulty or worsening fever.
- Take the medicine at consistent times for better results.
Who Should Be Extra Careful
- Individuals with liver or kidney disease
- Patients taking multiple chronic medications
- Elderly individuals at higher risk of complications
- People with complex medical conditions requiring close monitoring
Usage
Proper administration of this dual-action oral antiviral medication requires strict compliance with timing, careful dosage adjustment based on organ function, and comprehensive evaluation of potential drug-drug interactions.
Administration Instructions
Initiate Within the 5-Day Window: Therapy must be started as soon as possible after a positive viral diagnosis and strictly within 5 days of the initial onset of symptoms.
Swallow the Tablets Whole: Take all tablets in the dose together with water. Do not chew, crush, split, or dissolve the pills, as this can interfere with the structured release of the active molecules.
Flexible with Meals: This medication can be taken either with food or on an empty stomach; however, maintaining a consistent schedule helps ensure steady bloodstream levels.
Complete the Full 5-Day Cycle: Even if you begin to feel significantly better, you must finish all 5 days of treatment to prevent viral rebound or incomplete suppression.
Perform a Strict Drug Interaction Check: Because the Ritonavir component purposefully slows down hepatic CYP3A liver enzyme pathways, you must review all daily medications with a provider to avoid severe, toxic interactions.
Uses
Paxobrook Tablet functions as a highly targeted viral protease inhibitor regimen designed to halt early-stage cellular replication and viral spread throughout the body.
Treatment of Mild-to-Moderate Viral Infection: Actively manages early-stage symptoms to prevent the progression of illness in patients who are highly vulnerable to severe health outcomes.
Intervention for High-Risk Individuals: Provides crucial therapeutic support for elderly individuals, immunocompromised patients, or those with underlying chronic health conditions (such as diabetes, severe asthma, or cardiovascular disease).
Reduction of Viral Load: Rapidly lowers the concentration of active viral particles circulating within the respiratory tract and bloodstream, accelerating recovery and shortening the duration of systemic fatigue.
Prevention of Emergency Hospitalization: Lowers the clinical likelihood that an infection will progress into a severe lower-respiratory crisis, effectively reducing the burden on acute care medical facilities.
Side Effects
Common Side Effects
- Altered taste or metallic taste in mouth
- Diarrhea
- Nausea
- Vomiting
- Headache
- Fatigue or weakness
- Muscle aches
Less Common Side Effects
- Loss of appetite
- Abdominal discomfort
- Dizziness
- Mild rash
- Increased blood pressure in some cases
- Sleep disturbances
Serious Side Effects
| Serious Effect | Warning Sign |
|---|---|
| Liver problems | Yellowing of skin or eyes, dark urine, severe fatigue |
| Severe allergic reaction | Swelling, rash, difficulty breathing |
| Heart rhythm issues | Irregular heartbeat, chest discomfort |
| Severe gastrointestinal issues | Persistent vomiting or dehydration |
| Drug toxicity effects | Unusual muscle pain or extreme weakness |
Important Safety Advice
- Stop using Paxobrook Tablet (Nirmatrelvir + Ritonavir) and seek medical help if serious reactions occur.
- Mild side effects are usually temporary and improve during or after treatment.
- Stay well hydrated and rest adequately during therapy.
FAQs
Q: What is the product used for?
A: Paxobrook Tablet is a dual-action oral antiviral medication used to treat mild-to-moderate viral infections in patients who are at high risk of progressing to severe illness, complications, or emergency hospitalization.
Q: How does this co-packaged medication work?
A: It features an advanced viral protease inhibitor regimen. The Nirmatrelvir component stops the virus from replicating, while the Ritonavir component acts as a metabolic booster to keep the antiviral active in your body for longer.
Q: What is the standard treatment schedule for these tablets?
A: The standard treatment course requires taking the medication twice daily, in the morning and evening, for 5 consecutive days. For maximum efficacy, therapy must be started within 5 days of your first symptoms appearing.
Q: Do I need to take all the tablets in the blister section together?
A: Yes, a standard dose consists of taking 3 tablets simultaneously: 2 pink Nirmatrelvir tablets (150 mg each) and 1 white Ritonavir tablet (100 mg), unless a doctor has specifically modified your dose due to kidney issues.
Q: Can the tablets be crushed or broken for easier swallowing?
A: No, you must swallow all tablets whole with a full glass of water. Do not chew, break, or crush the medication, as this can destroy the film coating and alter how the active ingredients dissolve.
Q: What should I do if I forget to take a scheduled dose?
A: If it has been less than 6 hours since your missed time, take the dose immediately. If more than 6 hours have passed, skip that dose entirely and take your next regular dose at its scheduled time; never take two doses at once.
Q: What is the "Paxlovid mouth" side effect often associated with this type of treatment?
A: Many patients notice a temporary, distinct metallic or bitter taste in their mouth during the 5-day cycle. This is a common, non-harmful side effect of the protease inhibitor regimen that disappears completely once therapy ends.
Interactions
| Medicine / Substance | Interaction Effect |
|---|---|
| Statins | May increase risk of muscle toxicity. |
| Blood thinners | Can alter bleeding risk and levels. |
| Anti arrhythmics | May cause serious heart rhythm disturbances. |
| Anticonvulsants | Can reduce antiviral effectiveness. |
| Sedatives / sleeping pills | Increased sedation or drowsiness. |
| Steroids | May increase steroid levels in body. |
| Herbal products (St John’s Wort) | Reduces effectiveness of treatment. |
Important Drug Interaction Advice
- Use Paxobrook Tablet (Nirmatrelvir + Ritonavir) only after reviewing all ongoing medicines.
- Avoid combining with medicines that affect liver enzymes unless advised.
- Inform about cholesterol, heart, or seizure medicines before starting treatment.
- Monitor for unusual symptoms like dizziness, muscle pain, or irregular heartbeat.
- Do not start or stop any medicine without proper guidance during treatment.
Safety Reminder
- This medicine has multiple clinically important interactions, so full medicine disclosure is essential before use.
| Manufacturer | : | Healing Pharma |
| Trade Name | : | |
| Generic Search | : | Nirmatrelvir Tablets + Ritonavir Tablets |
| Strength | : | 150mg,100mg |
Latest Products
